ID   Pari-ICR
AC   CVCL_VR47
DR   Wikidata; Q98128482
RX   PubMed=30243716;
RX   PubMed=31244288;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Iranian.
CC   Doubling time: ~22 hours (PubMed=31244288).
CC   Omics: Array-based CGH.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=30243716; DOI=10.1016/j.bbrc.2018.09.087;
RA   Ghaderi F., Ahmadvand S., Ramezani A., Montazer M., Ghaderi A.;
RT   "Production and characterization of monoclonal antibody against a
RT   triple negative breast cancer cell line.";
RL   Biochem. Biophys. Res. Commun. 505:181-186(2018).
//
RX   PubMed=31244288; DOI=10.31557/APJCP.2019.20.6.1683;
RA   Ghaderi F., Mehdipour F., Hosseini A., Talei A., Ghaderi A.;
RT   "Establishment and characterization of a new triple negative breast
RT   cancer cell line from an Iranian breast cancer tissue.";
RL   Asian Pac. J. Cancer Prev. 20:1683-1689(2019).
//